References
1. https://www.who.int/ru/news-room/fact-sheets/detail/diabetes
2. WHO. Scientific researches that were made with the aim to achieve global health service coverage. World Health Report 2013 ISBN: 978 92 4 156459 5
3. King P., Peacock I., Donnelly R. The UK prospective diabetes study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999; 48 (5): 643-8. doi:10.1046/j.1365-2125.1999.00092.x
4. Zhang Y., Hu G., Yuan Z., Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2012; 7 (8): e42551.
5. Dluhy R.G., McHanon G.T. Intensive glycemic control in the ACCORD and ADVANCE trials. N Engl J Med. 2008; 358: 2630-3.
6. Dedov I.I., Mel'nichenko G.A., Fadeev V.F. Endocrinology. Moscow: GEOTAR-Media; 2007: 432 p. (in Russian)
7. Cefalu W. T. Insulin resistance: cellular and clinical concepts. Exp Biol Med (Maywood). 2001; 226 (1): 13-26. DOI: 10.1177/153537020122600103
8. De Meyts P. The insulin receptor and its signal transduction network. In: De Groot L.J., Chrousos G., Dungan K., Feingold K.R., Grossman A., Hershman J.M., et al. (eds.) Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2017.
9. Sparrow L.G., Macaulay S.L. Insulin receptor complex and signaling by insulin. In: Bradshow R.A., Denis E.A. (eds). Hand Book of cell signaling. Academic Press, 2004; (1): 293-7.
10. Ametov A.S., Tertychnaya E.A. Insulin resistance and lipotoxicity-2 facets of one problem. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2019; 8 (2): 25-33. doi: 10.24411/2304-9529-2019-12003.(in Russian)
11. Taranushenko T.E., Oorzhak U.S., Salmina A.B., Kiseleva N.G., Panfilova V.N. Disorders of carbohydrate metabolism and insulin resistance in obesity in children. Poliklinika [Policlinic]. 2017; (Special Issue: Endocrinology): 37-45. (in Russian)
12. Gardner D.G., Shobeck D., eds. Greenspan’s basic and clinical endocrinology. 8th ed. New York: McGraw-Hill; 2007.
13. Surya M., Artham M.D., Lavie C.J. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J. 2009; 9 (3): 124-32.
14. Wang Y., Rimm E.B., Stampfer M.J., et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005; 81 (3): 555-63.
15. Yusuf S., Hawken S., Ounpuu S., et al. INTERHEART Study investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005; 366: 1640-9.
16. Hu G., Tuomilehto J., Silventoinen K., et al. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J. 2004; 24: 2212-9.
17. Lofgren I., Herron K., Zern T., et al. Waist circumference is a better predictor than body mass index of coronary heart disease risk in overweight premenopausal women. J Nutr. 2004; 134: 1071-6.
18. Ametov A.S. Obesity. A modern view of pathogenesis and therapy. 2019; 1. Moscow: GEOTAR-Media, 382 p. (in Russian)
19. Diabetes mellitus: diagnosis, treatment, prevention. Edited by I.I Dedov, M.V. Shestakova. Moscow: Medical News Agency; 2011: 808 p. (in Russian)
20. Shestakova M.V., Breskina O. Yu. Insulin resistance: pathophysiology, clinical manifestations, treatment approaches. Consilium medicum. 2002; 4 (10): 523-7. (in Russian)
21. Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies. Diabet Med. 2009; 26 (12): 1185-92.
22. Ametov A.S. Type 2 diabetes mellitus. Problems and Solutions. Moscow: GEOTAR-Media; 2012: 704 p. (in Russian)
23. Cersosimo E., Triplitt C., Solis-Herrera C., et al. Pathogenesis of type 2 diabetes mellitus, 2018. [Electronic resource]. URL: https://www. ncbi.nlm.nih.gov/books/NBK279115/ (access date: 01.10.2019).
24. Drapkina O.M., Shifrina Yu.O. Molecular mechanisms of insulin resistance. Arterial’naya Gipertenziya [Arterial Hypertension]. 2010; 16 (5): 436-40. (in Russian)
25. Du X.L., Edelstein D., Dimmeler S., Ju Q., Sui C., Brownlee M. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest. 2001; 108 (9): 1341-8.
26. Xiao C., Giacca A., Lewis G.F. Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and p-cell dysfunction in humans. Diabetes. 2011; 60 (3): 918-24.
27. Ametov A.S., Prudnikova M.A. Prophylactic release metformin is a new standard un the treatment of type 2 diabetes. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training]. 2015; 1 (10): 19-26. (in Russian)
28. Viscoli C.M., Inzucchi S.E., Young L.H., et al. Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial. J Clin Endocrinol Metab. 2017; 102 (3): 914-22. DOI: 10.1210/jc.2016-3237.
29. Instruction leaflet for medical use of the medicinal product Subetta. (Electronic resource). URL: https: //grls.rosminzdrav.ru/Grls_View_v2.aspx? RoutingGuid = b7a7b4b3-da1c-4c2d-9511-c1c319841ba8 & t = (access date 11.02.2020).
30. Gorbunov E.A., Nicoll J., Kachaeva E.V., Tarasov S.A., Ep-shtein O.I. Subetta increases phosphorylation of insulin receptor p-subinit alone and in the presence of insulin. Nutr Diabetes. 2015; 5 (7): е169. DOI: 10.1038nutd.2015.20
31. Nicoll J., Gorbunov E.A., Tarasov S.A. Epstein O. I. Subetta treatment increases adiponectin secretion by mature human adipocytes in vitro. Intern J Endocrinol. 2013; 2013: 925874. DOI: 10.155/2013/9 2 5 8 74.
32. Omilaenko N.V., Vorobev S.V., Nazheva M.I., Demidov I.A. The effectiveness of therapy based on the use of midget dozes of antibodies to C-end fragment beta-subunit of the receptor for insulin and antibodies to endothelial no- synthase in patients with non-alcoholic fatty liver disease with mellitus diabetes typ. Fundamental'nye issledovaniya [Fundamental Research]. 2015; (1-9): 1888-92. (in Russian)
33. Rogova N.V., Kulikova I.V., Statsenko V.I., Ryazanova A. Yu., Sergeeva S.A., Epshteyn O.I. Comparative efficacy of antibodies to C-terminal fragment of beta-subunit insulin receptor in patients with type 2 diabetes mellitus. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta [Journal of Volgograd State Medical University]. 2011; (1): 26-8. (in Russian)
34. Rogova N.V., Kulikova I.V., Statsenko V.I., Ostrovskaya V.I. Effect of antibodies to c-final fragment of p-subunit insulin receptor on the quality of life indicators in patients with type 2 diabetes. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta [Journal of Volgograd State Medical University]. 2011; (2): 46-8. (in Russian)
35. Vorob'yev S.V., Petrovskaya E.U., Kuz'menko N.A., Khripun I.A. А new drug in the complex therapy of diabetes mellitus. Post-registration experience in patients with type 1 and type 2 diabetes mellitus. Medit-sinskiy sovet [Medical Council]. 2018; (16): 29-34. (in Russian)
36. Mkrtumyan A., Romantsova T., Vorobiev S., Volkova A., Vorokho-bina N., Tarasov S., et al. Efficacy and safety of Subetta add-on therapy in type 1 diabetes mellitus: The results of a multicenter, double-blind, placebo-controlled, randomized clinical trial. Diabetes Res Clin Pract. 2018; 142: 1-9.
37. A Randomized, multicenter, double-blind, parallel-group, placebo-controlled trial of efficacy and safety of Subetta in the combined treatment of patients with type II diabetes mellitus. Protocol MMH-SU-004-001 of 10/17/2017. Resolution of the Ministry of Healthcare of the Russian Federation No. 174 dated July 31, 2012 NCT01868646. (in Russian)
38. Mkrtumyan A.M. VITA Observation Program: Evaluation of the eectiveness and safety of the drug Subetta in the complex therapy of type 2 diabetes in ambulatory patients. Effektivnaya farmakoterapiya. Endokrinologiya [Effective Pharmacotherapy. Endocrinology]. 2020; 16 (2): 12-7. (in Russian)